{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:44:06Z","timestamp":1787010246586,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:p>\n                    Smoldering-type and chronic-type adult T-cell leukemia\/lymphomas (ATLL) patients have relatively indolent clinical courses, but often progress into aggressive lymphoma-type and acute-type disease. We examined the roles of transcription factor C-MYC and its ubiquitin ligase FBXW7 in tumor tissues from 137 patients with ATLL. Immunohistochemical tests showed \u226550% of lymphoma cells in 78.7% (48\/61) of lymphoma-type, and 64.9% (24\/37) of acute-type samples expressed C-MYC, significantly higher than was seen in smoldering-type (3.6%) and chronic-type (9.1%) samples (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.01). Real-time polymerase chain reaction showed\n                    <jats:italic toggle=\"yes\">C-MYC<\/jats:italic>\n                    mRNA expression in lymphoma-type and acute-type samples were significantly higher than in smoldering-type (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.01). C-MYC expression was highly correlated with its mRNA levels (\u03c1=0.65,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001), chromosomal amplification and duplication (\u03c1=0.3,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.045) and MIB1 labeling index (\u03c1=0.69,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001). Expression of FBXW7 protein and mRNA in lymphoma-type samples were significantly lower than those of smoldering-type (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.01 for each), and both were inversely correlated with C-MYC (protein: \u03c1=\u22120.4,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0002; mRNA: \u03c1=\u22120.31,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.015). Seven patients with smoldering-type or chronic-type ATLL converted to acute-type, in 4 of whom C-MYC expression increased from &lt;50% to \u226550%. Patients with \u226550% C-MYC or MIB1 had significantly worse prognosis than those with &lt;50% C-MYC (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0004) or MIB1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001), as did those with \u22657.5\n                    <jats:italic toggle=\"yes\">C-MYC<\/jats:italic>\n                    mRNA scores (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.033); whereas significantly better prognosis was associated with \u226550% FBXW7 protein (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0006) or \u22650.17\n                    <jats:italic toggle=\"yes\">FBXW7<\/jats:italic>\n                    mRNA (\n                    <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                    0.016). C-MYC and FBXW7 affect ATLL proliferation and progression, and low\n                    <jats:italic toggle=\"yes\">FBXW7<\/jats:italic>\n                    may increase C-MYC expression. C-MYC was a critical prognostic factor in ATLL patients.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000000871","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T09:02:23Z","timestamp":1494579743000},"page":"1139-1149","source":"Crossref","is-referenced-by-count":24,"title":["C-MYC and Its Main Ubiquitin Ligase, FBXW7, Influence Cell Proliferation and Prognosis in Adult T-cell Leukemia\/Lymphoma"],"prefix":"10.1097","volume":"41","author":[{"given":"Yasuhito","family":"Mihashi","sequence":"first","affiliation":[{"name":"Pathology"},{"name":"Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Internal Medicine, Division of Medical Oncology, Hematology and Infectious Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[{"name":"Division of Hematology and Immunology, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monji","family":"Koga","sequence":"additional","affiliation":[{"name":"Dermatology, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Urabe","sequence":"additional","affiliation":[{"name":"Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Momosaki","sequence":"additional","affiliation":[{"name":"Pathology, Clinical Research Center, National Hospital Organization Kyushu Medical Center, Fukuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Kiyomi","sequence":"additional","affiliation":[{"name":"Academia, Industry and Government Collaborative Research Institute of Translational Medicine for Life Innovation, Fukuoka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/MCB.19.7.4672","article-title":"C-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points","volume":"19","author":"Mateyak","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/sj.onc.1202592","article-title":"The proto-oncogene c-Myc and apoptosis","volume":"17","author":"Hoffman","year":"1998","journal-title":"Oncogene"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/sj.onc.1202749","article-title":"Mysterious liaisons: the relationship between c-Myc and the cell cycle","volume":"18","author":"Obaya","year":"1999","journal-title":"Oncogene"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2015.118","article-title":"Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP","volume":"28","author":"Xu-Monette","year":"2015","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.15252\/embj.201490252","article-title":"Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes","volume":"34","author":"Preston","year":"2015","journal-title":"EMBO J"},{"key":"R12-20230922","first-page":"1","article-title":"Regulation of glucose metabolism in T cells: new insight into the role of Phosphoinositide 3-kinases","volume":"247","author":"Finlay","year":"2012","journal-title":"Front Immunol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.molimm.2015.07.027","article-title":"Metabolic regulation of T-cell differentiation and function","volume":"68","author":"Park","year":"2015","journal-title":"Mol Immunol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.20386","article-title":"Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach","volume":"46","author":"Thorns","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"18261","DOI":"10.1073\/pnas.0606108103","article-title":"NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth","volume":"103","author":"Palomero","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"Starza","year":"2014","journal-title":"Blood"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"9085","DOI":"10.1073\/pnas.0402770101","article-title":"The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation","volume":"101","author":"Welcker","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1182\/blood.V95.6.2104","article-title":"c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover","volume":"95","author":"Bahram","year":"2000","journal-title":"Blood"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1084\/jem.20062299","article-title":"Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis","volume":"204","author":"Onoyama","year":"2007","journal-title":"J Exp Med"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1073\/pnas.1601537113","article-title":"Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients","volume":"113","author":"Yeh","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia\u2013lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Hematol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia\u2013lymphoma","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2141.1998.00582.x","article-title":"Management of adult T-cell leukaemia\/lymphoma","volume":"100","author":"Pawson","year":"1998","journal-title":"Br J Haematol"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/1097-0142(19910515)67:10<2605::AID-CNCR2820671034>3.0.CO;2-L","article-title":"Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia","volume":"67","author":"Yamada","year":"1991","journal-title":"Cancer"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1997.15.5.1778","article-title":"Deletions of p15 and\/or p16 genes as a poor-prognosis factor in adult T-cell leukemia","volume":"15","author":"Yamada","year":"1997","journal-title":"J Clin Oncol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood.V97.12.3875","article-title":"Comparative genomic hybridization analysis in adult T-cell leukemia\/lymphoma: correlation with clinical course","volume":"97","author":"Tsukasaki","year":"2001","journal-title":"Blood"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hon.2900040109","article-title":"Virus associated adult T-cell leukemia (ATL) in Japan: clinical, histological and immunohistological studies","volume":"4","author":"Kikuchi","year":"1986","journal-title":"Hematol Oncol"},{"key":"R31-20230922","first-page":"1481","article-title":"Chromosome abnormalities in adult T-cell leukemia\/lymphoma: a karyotype review committee report","volume":"52","author":"Kamada","year":"1992","journal-title":"Cancer Res"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2014.12.008","article-title":"Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)\/c-MYC","volume":"476","author":"Romeo","year":"2015","journal-title":"Virology"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"16288","DOI":"10.1016\/S0021-9258(18)41998-9","article-title":"Transactivation of the c-Myc promoter by human T cell leukemia virus type 1 tax is mediated by NF\u03baB","volume":"23","author":"Duyao","year":"1992","journal-title":"J Biol Chem"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","article-title":"Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia","volume":"73","author":"Kamihara","year":"1994","journal-title":"Cancer"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia\u2013lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1006\/excr.1998.4381","article-title":"Analysis of Tax-expressing cell lines generated from HTLV-I tax-transgenic mice: correlation between c-Myc overexpression and neoplastic potential","volume":"247","author":"Saggioro","year":"1999","journal-title":"Exp Cell Res"},{"key":"R38-20230922","first-page":"2403","article-title":"Selective cooperation of HTLV-1-encoded p40tax-1 with cellular oncoproteins in the induction of hematopoietic cell proliferation","volume":"12","author":"Miyazaki","year":"1996","journal-title":"Oncogene"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/bjc.2011.509","article-title":"Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma","volume":"106","author":"Kurashige","year":"2012","journal-title":"Br J Cancer"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"34439","DOI":"10.1074\/jbc.M110.152306","article-title":"MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7","volume":"285","author":"Xu","year":"2010","journal-title":"J Biol Chem"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.20122516","article-title":"The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell lymphoblastic leukemia","volume":"210","author":"Mansour","year":"2013","journal-title":"J Exp Med"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1158\/0008-5472.CAN-14-1470","article-title":"Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia","volume":"74","author":"Schubbert","year":"2014","journal-title":"Cancer Res"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1162981","article-title":"FBXW7 targets mTOR for degeneration and cooperates with PTEN in tumor suppression","volume":"321","author":"Mao","year":"2008","journal-title":"Science"},{"key":"R44-20230922","doi-asserted-by":"crossref","first-page":"e89388","DOI":"10.1371\/journal.pone.0089388","article-title":"FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors","volume":"9","author":"Jardim","year":"2014","journal-title":"PLoS ONE"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:38:49Z","timestamp":1695407929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201708000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000871","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}